A Randomized, Multi-center Study to Assess the Effect of Darbepoetin Alfa (Aranesp®) for the Treatment of Anemia in Patients With Advanced Hormone Independent Prostate Cancer and Anaemia
Phase of Trial: Phase II/III
Latest Information Update: 03 Aug 2017
At a glance
- Drugs Darbepoetin alfa (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 03 Dec 2015 Status changed from active, no longer recruiting to discontinued, according to ClinicalTrials.gov record.
- 25 Feb 2008 Status changed from recruiting to in progress.